Skip to content

Effect of cupping therapy on pain and function in persistent inespecific low back pain: a randomized controlled trial

Effect of cupping therapy on pain and function in persistent inespecific low back pain: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3s7g4t
Enrollment
Unknown
Registered
2020-01-07
Start date
2019-09-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persistent Non specifict Low Back Pain

Interventions

The treatment will be performed for a period of two and a half weeks with a total of 5 sessions for each group. The interventions are divided into two phases that will occur during the session. Dates
Other
H02.004

Sponsors

Universidade Federal de Pernambuco
Lead Sponsor
Universidade Federal de Pernambuco
Collaborator

Eligibility

Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: Age between 18 and 59 years old, Present persistent nonspecific low back pain

Exclusion criteria

Exclusion criteria: Pregnant women; Women in the postpartum period; Patients who use anticoagulant; Patients who have donated blood in the last 3 months; Anemia; Red flag patients (vertebral fracture; vertebral tumor; vertebral infection; equine tail syndrome; progressive neurological impairment); Systemic diseases (autoimmune; infectious; vascular insufficiency; renal insufficiency; hepatic insufficiency; neoplasia); Fibromyalgia; Lumbar disc herniation; Symptomatic irradiated pain (positive Laségue test); Anterior spine surgery; People with open and poorly healed wounds; Inflamed skin; Alteration of skin integrity; Open fractures; Previous experience of physical therapy treatment in the last 3 months; People who have had previous wind therapy treatment

Design outcomes

Primary

MeasureTime frame
Evaluate the Pain intensity: Discrete quantitative variable expressed from 0 to 10 by the Visual Analog Scale (VAS). ;Evaluate the Functional disability: Ordinal qualitative variable expressed by the Oswestry Disability Index Disability Questionnaire classifying the disability as: minimal disability (1), moderate disability (2), severe disability (3), very severe disability (4) and incapable (5)

Secondary

MeasureTime frame
Evaluate the Quality of life: Discrete quantitative variable expressed from 0 to 100 by the Brazilian version of the SF-36 quality of life questionnaire ;Evaluate the Weekly analgesic use: Nominal categorical variable, referring to the administration or not of analgesic during the week, expressed as “yes” or “no”. Item obtained through closed question present in the analgesic and pain diary.;Evaluate the Amount of analgesic administered: Discrete quantitative variable, referring to the amount of analgesic administered during the week through the analgesic and pain diary, expressed in cardinal number. Later the quantity will be counted in a table with weekly distribution. ;Evaluate the Global perception of change: Quantitative variable expressed from 0 to 7 through the global perception change scale

Countries

Brazil

Contacts

Public ContactMarianna ;MARIANNA Salemi;SALEMI

Universidade Federal de Pernambuco;Universidade Federal de Pernambuco

mariannasalemifisio@gmail.com;mariannasalemifisio@gmail.com+558199670100;81996780100

Outcome results

None listed

Source: REBEC (via WHO ICTRP)